About
Dr. John J. Savarese is a Managing Director at Montreux Equity Partners. Dr. Savarese is a board director or observer for several Montreux portfolio companies, including MAKO Surgical (NASDAQ: MAKO), Bayhill Therapeutics, Pivot Medical (Chairman), Avantis Medical Systems, Novalar Pharmaceuticals, and KFx Medical. In addition, he was actively involved in Montreux’s investment decisions in Aryx (NASDAQ: ARYX), Orexigen (NASDAQ: OREX), Somaxon (NASDAQ: SOMX), Cerexa (Forest labs), Novacardia (Merck), Renal CarePartners, Asthmatx, Glaukos, and Novostent. Prior to joining Montreux, Dr. Savarese served as Director of Business Development and Marketing with the entrepreneurial team at NeurogesX (NASDAQ: NGSX), a Montreux portfolio company focused on the treatment of neuropathic pain.
Position in the VCSift Database
- • 2 investors at Avantis Medical Systems are tracked.
- • 145 investors hold the Board of Directors role in VCSift. John J. Savarese is one of them.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
Contact Information
Find more investors like John
Search Investors